In this regard, Nie and co-authors [63] found that high tissue expression levels of MNX1-AS1, LINC00330, and LSAMP-AS1 genes in laryngeal cancer correlated with low survival rates, and the high-risk group was sensitive to AKT (protein kinase B) inhibitors. This evidence concerns the gene AKT1 and laryngeal carcinoma.